Biotech

All Articles

Lilly- backed weight management biotech files IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to...

Aelis' marijuana use drug fails phase 2b, driving Indivior to review $100M choice

.Aelis Farma's chances of protecting a quick, beneficial choice on a $100 million possibility paymen...

ProKidney halts stage 3 trial certainly not required for cell treatment confirmation

.ProKidney has actually ceased one of a set of phase 3 trials for its tissue therapy for renal condi...

Vaxcyte rises on 'remarkable' 31-valent PCV succeed versus Pfizer

.Vaxcyte revealed what professionals referred to as "impressive" stage 1/2 data for its own 31-valen...

Recursion's brain disease test shows little evidence of efficiency

.Recursion has stumbled via an early examination of its tech-enabled method to medication discovery,...

Acepodia, Pfizer click together for chemistry-based tissue treatment

.Phone it a scenario of good chemistry: Acepodia, a biotech based upon Nobel Champion science, is pa...

Praxis epilepsy medicine decreases confiscations in phase 2 hearing

.Praxis Accuracy Medicines has scored another midphase gain in epilepsy this year, along with its ow...

Three directors resign as Dyne messages mixed data for DMD prospect

.After leaving a clinical hold numerous years back, Dyne Rehab has actually revealed brand-new phase...

Arrowhead fires off period 3 data in uncommon metabolic ailment ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has actually shown its hand before a prospective face-off with Ionis, pos...

Pfizer, Valneva show lyme ailment chance successful for second booster

.Pfizer and also Valneva may have about two more years to wait before they help make the initial con...